Search results
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 1 day agoFulcrum and Sanofi will equally share future global development costs. FULC retains full...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 1 day agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 2 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 2 days agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 7 days agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Biotech CEO: Bayh-Dole 'fix' won't lower drug prices - Boston Business Journal
The Business Journals· 8 hours agoCalled the Bayh-Dole Act, the law has impacted virtually every sector of the U.S. economy, establishing the U.S. as the world leader when it comes to innovation. The bipartisan Bayh-Dole Act ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Markets News, May 13, 2024: Stocks End Mixed As Investors Await Key Inflation Data; Dow's Winning...
Investopedia· 4 days agoIncyte's CEO said the repurchase authorization reflects the firm's strong confidence in its...